Annual Total Long Term Liabilities
$6000.00
-$63.00 K-91.30%
31 December 2023
Summary:
Achieve Life Sciences annual total long term liabilities is currently $6000.00, with the most recent change of -$63.00 thousand (-91.30%) on 31 December 2023. During the last 3 years, it has fallen by -$71.00 thousand (-92.21%). ACHV annual total long term liabilities is now -99.97% below its all-time high of $20.24 million, reached on 31 December 2009.ACHV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$9.82 M
+$1.02 M+11.57%
30 September 2024
Summary:
Achieve Life Sciences quarterly total long term liabilities is currently $9.82 million, with the most recent change of +$1.02 million (+11.57%) on 30 September 2024. Over the past year, it has dropped by -$6.39 million (-39.43%). ACHV quarterly long term liabilities is now -51.47% below its all-time high of $20.24 million, reached on 31 December 2009.ACHV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACHV Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -91.3% | -39.4% |
| 3 y3 years | -92.2% | +10000.0% |
| 5 y5 years | -50.0% | +4533.5% |
ACHV Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | at low | -39.4% | |
| 5 y | 5 years | -100.0% | at low | -39.4% | |
| alltime | all time | -100.0% | -51.5% |
Achieve Life Sciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.82 M(+11.6%) |
| June 2024 | - | $8.80 M(>+9900.0%) |
| Mar 2024 | - | $0.00(-100.0%) |
| Dec 2023 | $6000.00(-91.3%) | $6000.00(-100.0%) |
| Sept 2023 | - | $16.22 M(+2.8%) |
| June 2023 | - | $15.77 M(>+9900.0%) |
| Mar 2023 | - | $54.00 K(-21.7%) |
| Dec 2022 | $69.00 K(-99.5%) | $69.00 K(-99.6%) |
| Sept 2022 | - | $15.76 M(+2.0%) |
| June 2022 | - | $15.46 M(+1.9%) |
| Mar 2022 | - | $15.17 M(+1.7%) |
| Dec 2021 | $14.92 M(>+9900.0%) | $14.92 M(>+9900.0%) |
| Sept 2021 | - | $23.00 K(-43.9%) |
| June 2021 | - | $41.00 K(-30.5%) |
| Mar 2021 | - | $59.00 K(-23.4%) |
| Dec 2020 | $77.00 K(-51.6%) | $77.00 K(-18.1%) |
| Sept 2020 | - | $94.00 K(-14.5%) |
| June 2020 | - | $110.00 K(-6.8%) |
| Mar 2020 | - | $118.00 K(-25.8%) |
| Dec 2019 | $159.00 K(+1225.0%) | $159.00 K(-25.0%) |
| Sept 2019 | - | $212.00 K(-19.4%) |
| June 2019 | - | $263.00 K(-16.0%) |
| Mar 2019 | - | $313.00 K(+2508.3%) |
| Dec 2018 | $12.00 K(>+9900.0%) | $12.00 K(-20.0%) |
| Sept 2018 | - | $15.00 K(-16.7%) |
| June 2018 | - | $18.00 K(>+9900.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2017 | - | $16.00 K(-27.3%) |
| June 2017 | - | $22.00 K(-31.3%) |
| Mar 2017 | - | $32.00 K(-74.2%) |
| Dec 2016 | $124.00 K(+18.1%) | $124.00 K(+85.1%) |
| Sept 2016 | - | $67.00 K(-20.2%) |
| June 2016 | - | $84.00 K(-8.7%) |
| Mar 2016 | - | $92.00 K(-12.4%) |
| Dec 2015 | $105.00 K(+650.0%) | $105.00 K(-10.3%) |
| Sept 2015 | - | $117.00 K(-10.0%) |
| June 2015 | - | $130.00 K(+1.6%) |
| Mar 2015 | - | $128.00 K(+814.3%) |
| Dec 2014 | $14.00 K(-99.6%) | $14.00 K(-99.5%) |
| Sept 2014 | - | $2.87 M(-7.2%) |
| June 2014 | - | $3.10 M(-6.7%) |
| Mar 2014 | - | $3.32 M(-6.3%) |
| Dec 2013 | $3.54 M(-16.7%) | $3.54 M(-4.9%) |
| Sept 2013 | - | $3.73 M(-4.6%) |
| June 2013 | - | $3.91 M(-4.4%) |
| Mar 2013 | - | $4.09 M(-3.9%) |
| Dec 2012 | $4.25 M(-32.9%) | $4.25 M(-25.9%) |
| Sept 2012 | - | $5.74 M(-3.4%) |
| June 2012 | - | $5.94 M(-3.3%) |
| Mar 2012 | - | $6.14 M(-3.1%) |
| Dec 2011 | $6.34 M | $6.34 M(-59.2%) |
| Sept 2011 | - | $15.54 M(-5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2011 | - | $16.47 M(-5.8%) |
| Mar 2011 | - | $17.49 M(-4.5%) |
| Dec 2010 | $18.32 M(-9.5%) | $18.32 M(-8.4%) |
| Sept 2010 | - | $20.00 M(+15.6%) |
| June 2010 | - | $17.30 M(-4.1%) |
| Mar 2010 | - | $18.04 M(-10.9%) |
| Dec 2009 | $20.24 M(+1588.1%) | $20.24 M(+1496.2%) |
| Sept 2009 | - | $1.27 M(+1.0%) |
| June 2009 | - | $1.25 M(+3.0%) |
| Mar 2009 | - | $1.22 M(+1.7%) |
| Dec 2008 | $1.20 M(-82.8%) | $1.20 M(+3.1%) |
| Sept 2008 | - | $1.16 M(-82.8%) |
| June 2008 | - | $6.76 M(-1.4%) |
| Mar 2008 | - | $6.85 M(-1.8%) |
| Dec 2007 | $6.98 M(+25.9%) | $6.98 M(+152.1%) |
| June 2007 | - | $2.77 M(-33.4%) |
| Mar 2007 | - | $4.15 M(-25.0%) |
| Dec 2006 | $5.54 M(-51.4%) | $5.54 M(-20.9%) |
| Sept 2006 | - | $7.00 M(-18.5%) |
| June 2006 | - | $8.59 M(-14.1%) |
| Mar 2006 | - | $10.00 M(-12.4%) |
| Dec 2005 | $11.41 M(+4687.4%) | $11.41 M(+6614.8%) |
| Sept 2005 | - | $169.90 K(-11.9%) |
| June 2005 | - | $192.90 K(-10.6%) |
| Mar 2005 | - | $215.70 K(-9.5%) |
| Dec 2004 | $238.30 K(+97.6%) | $238.30 K(+390.3%) |
| Sept 2004 | - | $48.60 K(-11.5%) |
| June 2004 | - | $54.90 K(-31.9%) |
| Mar 2004 | - | $80.60 K(-33.2%) |
| Dec 2003 | $120.60 K(-55.7%) | $120.60 K(-24.5%) |
| Sept 2003 | - | $159.80 K(-19.3%) |
| June 2003 | - | $198.10 K(-15.9%) |
| Mar 2003 | - | $235.50 K(-13.4%) |
| Dec 2002 | $272.00 K(-86.4%) | $272.00 K(-11.6%) |
| Sept 2002 | - | $307.60 K(+12.1%) |
| June 2002 | - | $274.40 K(+157.7%) |
| Mar 2002 | - | $106.50 K(-94.9%) |
| Mar 1999 | - | $2.10 M(+5.0%) |
| Dec 1998 | $2.00 M(+122.2%) | $2.00 M(-4.8%) |
| Sept 1998 | - | $2.10 M(+10.5%) |
| June 1998 | - | $1.90 M(+26.7%) |
| Mar 1998 | - | $1.50 M(+66.7%) |
| Dec 1997 | $900.00 K(+125.0%) | $900.00 K(+800.0%) |
| Sept 1997 | - | $100.00 K(0.0%) |
| June 1997 | - | $100.00 K(-50.0%) |
| Mar 1997 | - | $200.00 K(-50.0%) |
| Dec 1996 | $400.00 K(-20.0%) | $400.00 K(+33.3%) |
| Sept 1996 | - | $300.00 K(-40.0%) |
| June 1996 | - | $500.00 K(+25.0%) |
| Mar 1996 | - | $400.00 K(-20.0%) |
| Dec 1995 | $500.00 K(-85.3%) | $500.00 K(-85.3%) |
| Sept 1995 | - | $3.40 M(0.0%) |
| Dec 1994 | $3.40 M | $3.40 M |
FAQ
- What is Achieve Life Sciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Achieve Life Sciences?
- What is Achieve Life Sciences annual total long term liabilities year-on-year change?
- What is Achieve Life Sciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Achieve Life Sciences?
- What is Achieve Life Sciences quarterly long term liabilities year-on-year change?
What is Achieve Life Sciences annual total long term liabilities?
The current annual total long term liabilities of ACHV is $6000.00
What is the all time high annual total long term liabilities for Achieve Life Sciences?
Achieve Life Sciences all-time high annual total long term liabilities is $20.24 M
What is Achieve Life Sciences annual total long term liabilities year-on-year change?
Over the past year, ACHV annual total long term liabilities has changed by -$63.00 K (-91.30%)
What is Achieve Life Sciences quarterly total long term liabilities?
The current quarterly long term liabilities of ACHV is $9.82 M
What is the all time high quarterly long term liabilities for Achieve Life Sciences?
Achieve Life Sciences all-time high quarterly total long term liabilities is $20.24 M
What is Achieve Life Sciences quarterly long term liabilities year-on-year change?
Over the past year, ACHV quarterly total long term liabilities has changed by -$6.39 M (-39.43%)